Maude Lands Its Biggest Retail Expansion Yet As Sexual Wellness Heats Up (Again)

Maude, a sexual wellness brand, is expanding into 600+ Target Beauty Studios and 400 Ulta Beauty stores. Founder Éva Goicochea notes the move targets different consumer bases. Ulta expects wellness to become a $1B category, with fiscal year sales projected at $13.1B-$13.2B. Maude, backed by Dakota Johnson, is approaching profitability and is sold through multiple retailers.

Original reporting
Published Sep 21, 2026, 4:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 5:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefSector analysis
Primary signal
$ULTA
Bullish
medium confidence
Mentioned
$ULTA · $TGT
Relevance
5/10
AlphAI data visualization · based on beautyindependent.com
Decision brief

The 30-second read

$ULTABullishLow
01

Why it matters

The rollout provides fresh retail exposure for both ULTA and TGT, potentially enhancing same‑store sales and reinforcing their wellness strategies.

02

Market read

Retailers' new partnership with Maude underscores a growing consumer focus on intimate care, offering modest upside for ULTA and TGT stocks.

03

What to watch

Supply‑chain constraints and pricing pressure could temper the expected sales boost.

Relevance 5/10Novelty 5/10Timing: current

Background

Maude, a private sexual‑wellness brand, is expanding into major U.S. retailers Target and Ulta, reflecting a resurgence in the category after a post‑pandemic lull.

Company-level read

Ticker impact

$ULTABullishMedium confidence
Context

Ulta Beauty adds Maude products to nearly 400 stores, expanding its sexual wellness offering.

Expected impact

Modest upside as new SKU assortment drives incremental traffic.

Evidence & confidence

Retail expansion is a fresh development but limited in scale; impact depends on consumer uptake.

$TGTBullishMedium confidence
Context

Target Beauty Studios will host Maude products in over 600 locations, marking its largest sexual‑wellness rollout.

Expected impact

Slight upside potential as the partnership may boost same‑store sales.

Evidence & confidence

First‑time inclusion of Maude at this scale is new information, but overall effect on earnings is modest.

Market effects

Signals renewed retailer focus on sexual wellness, potentially benefiting other beauty and wellness players.

U.S. retail sector sees incremental growth in the intimate‑care niche.

Highlights a broader trend of convergence between beauty and wellness globally.

Counterpoint

The niche market may be over‑hyped; consumer adoption could lag, limiting upside for ULTA and TGT.

Key entities

  • Maude

    Private sexual‑wellness brand expanding retail presence.

  • Ulta Beauty

    U.S. beauty retailer adding Maude products to its stores.

  • Target

    U.S. retailer launching Maude in Target Beauty Studios.

Related articles

$ULTAMed

How Investors May Respond To Ulta Beauty (ULTA) Analyst Upgrade

Ulta Beauty (ULTA) management discussed operational resilience at Barclays' conference, focusing on cost control and assortment discipline. Wells Fargo upgraded ULTA to Equal Weight, citing margin pressures and Target partnership changes. The company projects $14.9B revenue and $1.4B earnings by 2029, with risks including e-commerce competition and cost inflation. Analysts' views vary, with some seeing 15% upside and others 28% downside.

$UNPMed

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Ulta Beauty (NASDAQ:ULT

Analysts upgraded several companies: Needham upgraded Similarweb (SMWB) to Buy with a $11 target, Wolfe Research upgraded Paychex (PAYX) to Peer Perform, Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target, UBS upgraded Union Pacific (UNP) to Buy with a $339 target, and Barclays upgraded Alvotech (ALVO) to Overweight with a $8 target.